More importantly, there are clear political implications. When federally funded research shows that cannabis can have positive mental health benefits, it serves as fuel for legalization momentum and can help push for the rescheduling of marijuana later on through the Controlled Substances Act. Unfortunately, cannabis is still considered a Schedule 1 substance which, in other words, says that it has no accepted medical use.

After over fifty years of existence, the Drug Enforcement Administration has compiled a track record that would make any other federal agency blush with shame. They've lost the War on Drugs spectacularly, overseen the rise of the deadliest overdose crisis in American history, and spent hundreds of billions of taxpayer dollars with virtually nothing to show for it except overcrowded prisons and destroyed communities.

Here we go again, folks. Just when you think the cannabis prohibition debate might evolve beyond the same tired talking points from the 1980s, along comes the Concerned Women for America with their latest pearl-clutching manifesto on why marijuana should remain a Schedule I drug. Reading their recent piece felt like stepping into a time machine – one that's been stuck in reverse for about four decades.

The same study also noted that while there was a significant rise among 14 types of cancer, the good news was that there was a decrease of incidences among 19 other types of cancer. As a result, the mortality rate isn’t rising. However, being diagnosed with cancer is not something anyone can take lightly: it’s a genuinely scary diagnosis that can cause serious financial and emotional strain.

This shift isn't happening in a vacuum. It coincides with rising rates of anxiety and depression among teenage girls – 57% report persistent sadness compared to 29% of boys. Meanwhile, 40 states have legalized medical marijuana, normalizing cannabis as medicine rather than just recreation. For girls dealing with everything from menstrual cramps to social media-induced anxiety, a discreet vape pen offers relief without the stigma of traditional smoking.

A fascinating study out of Pennsylvania just delivered news that should terrify pharmaceutical executives and delight anyone who understands what real medicine looks like. According to research published in PLOS One, 58% of medical cannabis patients quit using it within a year, with nearly half stopping within just three months.

On one hand, we have U.S. v. Hemani, where the government wants to clarify that anyone who's ever touched cannabis should be permanently barred from exercising their Second Amendment rights. On the other, there's Canna Provisions v. Bondi, a direct challenge to the federal government's authority to criminalize state-legal cannabis operations. These cases represent the inevitable collision between outdated federal prohibition and the reality that most Americans – and most states – have moved on.

However, just because it can get you high doesn’t mean it has no place in medicine, even in pediatric care. It’s best not to oversimplify things and avoid ignoring the science because the studies and countless anecdotal evidence shows that THC, in the right doses and when administered under clinical supervision, is safe and effective for treating children.

Washington D.C. has seen no shortage of letters flooding the White House lately, each one desperately vying for President Trump's attention on cannabis policy. It's like watching rival children write to Santa, except instead of asking for toys, they're fighting over drug schedules and criminal justice reform.

Study participants were made to undergo 15-minute exposures each week to low THC, which consisted of 0.5% weed smoke, for more than a month. The smoke itself was delivered using a pump inside a vehicle. Meanwhile, after a one month washout period when they abstained from exposure, the participants were then asked to repeat the exposure in the same conditions but with high THC cannabis smoke this time. The researchers collected urine and hair samples after.